These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 12296743)

  • 1. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as novel HIV-1 integrase strand transfer inhibitors.
    Zhang RH; Chen GQ; Wang W; Wang YC; Zhang WL; Chen T; Xiong QQ; Zhao YL; Liao SG; Li YJ; Yan GY; Zhou M
    RSC Adv; 2024 Mar; 14(13):9020-9031. PubMed ID: 38500630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR Titration Studies in Z-DNA Dynamics.
    Choi SR; Oh KI; Seo YJ; Lee JH
    Methods Mol Biol; 2023; 2651():69-83. PubMed ID: 36892760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI by NMR: Probing CH-π Interactions in Protein-Ligand Complexes by NMR Spectroscopy.
    Platzer G; Mayer M; Beier A; Brüschweiler S; Fuchs JE; Engelhardt H; Geist L; Bader G; Schörghuber J; Lichtenecker R; Wolkerstorfer B; Kessler D; McConnell DB; Konrat R
    Angew Chem Int Ed Engl; 2020 Aug; 59(35):14861-14868. PubMed ID: 32421895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nature of ligand efficiency.
    Kenny PW
    J Cheminform; 2019 Jan; 11(1):8. PubMed ID: 30706294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated Fragmentation QM/MM Calculation of NMR Chemical Shifts for Protein-Ligand Complexes.
    Jin X; Zhu T; Zhang JZH; He X
    Front Chem; 2018; 6():150. PubMed ID: 29868556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An NMR-Guided Screening Method for Selective Fragment Docking and Synthesis of a Warhead Inhibitor.
    Khattri RB; Morris DL; Davis CM; Bilinovich SM; Caras AJ; Panzner MJ; Debord MA; Leeper TC
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery.
    Shoemark DK; Williams C; Fahey MS; Watson JJ; Tyler SJ; Scoltock SJ; Ellis RZ; Wickenden E; Burton AJ; Hemmings JL; Bailey CD; Dawbarn D; Jane DE; Willis CL; Sessions RB; Allen SJ; Crump MP
    J Med Chem; 2015 Jan; 58(2):767-77. PubMed ID: 25454499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using quantum mechanical approaches to study biological systems.
    Merz KM
    Acc Chem Res; 2014 Sep; 47(9):2804-11. PubMed ID: 25099338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5.
    Aguirre C; ten Brink T; Guichou JF; Cala O; Krimm I
    PLoS One; 2014; 9(7):e102300. PubMed ID: 25025339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BcL-xL conformational changes upon fragment binding revealed by NMR.
    Aguirre C; Ten Brink T; Walker O; Guillière F; Davesne D; Krimm I
    PLoS One; 2013; 8(5):e64400. PubMed ID: 23717610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragment-based drug discovery using NMR spectroscopy.
    Harner MJ; Frank AO; Fesik SW
    J Biomol NMR; 2013 Jun; 56(2):65-75. PubMed ID: 23686385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The description of protein internal motions aids selection of ligand binding poses by the INPHARMA method.
    Stauch B; Orts J; Carlomagno T
    J Biomol NMR; 2012 Nov; 54(3):245-56. PubMed ID: 23001323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing the principal component of ¹H, ¹⁵N-HSQC NMR spectral changes that reflect protein structural or functional properties: application to troponin C.
    Robertson IM; Boyko RF; Sykes BD
    J Biomol NMR; 2011 Sep; 51(1-2):115-22. PubMed ID: 21947920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexes of native ubiquitin and dodecyl sulfate illustrate the nature of hydrophobic and electrostatic interactions in the binding of proteins and surfactants.
    Shaw BF; Schneider GF; Arthanari H; Narovlyansky M; Moustakas D; Durazo A; Wagner G; Whitesides GM
    J Am Chem Soc; 2011 Nov; 133(44):17681-95. PubMed ID: 21939262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of trans-resveratrol in complex with the cardiac regulatory protein troponin C.
    Pineda-Sanabria SE; Robertson IM; Sykes BD
    Biochemistry; 2011 Mar; 50(8):1309-20. PubMed ID: 21226534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-FACE: an NMR based binding site mapping program for fast chemical exchange protein-ligand systems.
    Krishnamoorthy J; Yu VC; Mok YK
    PLoS One; 2010 Feb; 5(2):e8943. PubMed ID: 20174626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspectives on NMR in drug discovery: a technique comes of age.
    Pellecchia M; Bertini I; Cowburn D; Dalvit C; Giralt E; Jahnke W; James TL; Homans SW; Kessler H; Luchinat C; Meyer B; Oschkinat H; Peng J; Schwalbe H; Siegal G
    Nat Rev Drug Discov; 2008 Sep; 7(9):738-45. PubMed ID: 19172689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of quantitative (1)H NMR chemical shift changes for ligand docking into barnase.
    Cioffi M; Hunter CA; Packer MJ; Pandya MJ; Williamson MP
    J Biomol NMR; 2009 Jan; 43(1):11-9. PubMed ID: 18979065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations.
    McCoy MA; Wyss DF
    J Am Chem Soc; 2002 Oct; 124(39):11758-63. PubMed ID: 12296743
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.